Key result
Metabolic syndrome is linked to early diastolic dysfunction, mitochondrial impairment, and microvascular-driven myocardial fibrosis.
Why the study?
The study aimed to evaluate early structural and functional myocardial changes in patients with metabolic syndrome.
Observational
Patients with metabolic syndrome exhibit early structural and functional myocardial changes, including diastolic dysfunction and fibrosis, highlighting the need for early intervention to prevent heart failure.
Answers are grounded in this paper and cite their sources.
May indicate heightened HFpEF risk in metabolic syndrome; leaves open causality and preventive value of mitochondrial or microvascular targets.
This study aimed to evaluate early structural and functional myocardial changes in patients with metabolic syndrome. A clinico-morphological approach was applied, including anthropometric, biochemical, and echocardiographic assessments[1,2,3]. Insulin resistance was evaluated using the HOMA-IR index. The results demonstrated early diastolic dysfunction, mitochondrial impairment, and microvascular disturbances, contributing to fibrotic changes in the myocardium. These findings highlight the importance of early diagnosis and pathogenetic treatment to prevent progression to heart failure.
No takes yet. Share an insight, caveat, or question.
Nigoraxon Ravshanbek kizi Madraximova (2026) conducted an observational in Metabolic syndrome. Patients with metabolic syndrome demonstrated early diastolic dysfunction, mitochondrial impairment, and microvascular disturbances contributing to fibrotic changes in the myocardium.
Synapse has enriched 10 related papers. Consider them for comparative context: